THC

Over the past six months (March 2026 - September 2026), Tenet Healthcare Corp. experienced several stock-impacting events. On July 23, 2026, the company reported strong Q2 2026 results, raising its financial outlook, which led to a 17.17% increase in stock price, with adjusted diluted earnings per share increasing by 52.2% to $6.12. In the second quarter of 2026, Tenet repurchased 5.68 million shares for $1.042 billion, and its Board authorized a $2.0 billion increase to the share repurchase program, bringing the remaining authorization to $2.13 billion. On September 8, 2026, Tenet announced the upsizing and pricing of a $2.0 billion private offering of senior notes to refinance $1.5 billion in outstanding notes. The company also announced its participation in the Wells Fargo Healthcare Conference on September 2, 2026. Insider trading included Director Robert J. Kerrey selling 12,010 shares on September 14, 2026, and Director Nadja West selling 1,152 shares on September 2, 2026. BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating on September 22, 2026. The stock price gained 42.7% over the past 12 months as of September 17, 2026, and moved +37.68% over the past 365 days, outperforming the S&P500 Index by +12.49% over the past six months.